CapitalOne initiated coverage on Jasper Therapeutics with a new price target

8/11/23 9:34:25 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

CapitalOne initiated coverage of Jasper Therapeutics with a rating of Overweight and set a new price target of $7.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$JSPR

Date	Price Target	Rating	Analyst
2/13/2025	$38.00	Buy	UBS
12/6/2024	$63.00	Outperform	BMO Capital Markets
9/9/2024	$70.00	Mkt Outperform	JMP Securities
7/8/2024	$90.00	Buy	BTIG Research
6/27/2024	$86.00	Buy	Stifel
5/6/2024	$65.00	Buy	H.C. Wainwright
4/3/2024	$65.00	Outperform	Evercore ISI
3/28/2024	$70.00	Outperform	RBC Capital Mkts